Co-Authors
This is a "connection" page, showing publications co-authored by Hidetoshi Nomoto and Noriko Kinoshita.
Connection Strength
1.543
-
Time-course evaluation of the quantitative antigen test for severe acute respiratory syndrome coronavirus 2: The potential contribution to alleviating isolation of COVID-19 patients. J Infect Chemother. 2021 Nov; 27(11):1669-1673.
Score: 0.240
-
No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity. J Infect Chemother. 2021 Apr; 27(4):653-655.
Score: 0.231
-
Cautious handling of urine from moderate to severe COVID-19 patients. Am J Infect Control. 2020 08; 48(8):969-971.
Score: 0.221
-
Corrigendum to "Utility of the antigen test for coronavirus disease 2019: factors influencing the prediction of the possibility of disease transmission" [Int J Infect Dis 104 (2021) 65-72]. Int J Infect Dis. 2021 Aug; 109:323.
Score: 0.060
-
How we secured a COVID-19 convalescent plasma procurement scheme in Japan. Transfusion. 2021 07; 61(7):1998-2007.
Score: 0.059
-
Positive Ratio of Polymerase Chain Reaction (PCR) and Validity of Pre-Screening Criteria at an Outpatient Screening Center during the Early Phase of the COVID-19 Epidemic in Japan. Jpn J Infect Dis. 2021 Sep 22; 74(5):481-486.
Score: 0.058
-
Utility of the antigen test for coronavirus disease 2019: Factors influencing the prediction of the possibility of disease transmission. Int J Infect Dis. 2021 Mar; 104:65-72.
Score: 0.058
-
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19. J Clin Apher. 2021 Jun; 36(3):313-321.
Score: 0.057
-
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, Japan. Intern Med. 2020 Dec 15; 59(24):3131-3133.
Score: 0.057
-
Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severity. Infect Prev Pract. 2020 Dec; 2(4):100098.
Score: 0.057
-
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19. Gene. 2021 Jan 15; 766:145145.
Score: 0.056
-
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers. J Infect Chemother. 2021 Jan; 27(1):120-122.
Score: 0.056
-
Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020 Aug; 2(8):e0170.
Score: 0.056
-
COVID-19 can suddenly become severe: a case series from Tokyo, Japan. Glob Health Med. 2020 Jun 30; 2(3):174-177.
Score: 0.056
-
SARS-CoV-2 Screening Test for Japanese Returnees From Wuhan, China, January 2020. Open Forum Infect Dis. 2020 Jul; 7(7):ofaa243.
Score: 0.056
-
SARS-CoV-2 infection among returnees on charter flights to Japan from Hubei, China: a report from National Center for Global Health and Medicine. Glob Health Med. 2020 Apr 30; 2(2):107-111.
Score: 0.055
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 07; 289:113040.
Score: 0.055
-
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospital. Psychiatry Res. 2020 Apr 29; 289:113040.
Score: 0.055